Evaluation of Auditory Mirror-therapy for Tinnitus

Sponsor
Spaulding Rehabilitation Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05710172
Collaborator
Harvard University (Other)
50
1
2
8.8
5.7

Study Details

Study Description

Brief Summary

The investigators will evaluate the effects of wearing auditory mirror earmuffs on tinnitus and on audiometry.The auditory mirror earmuffs is a device that re-routes auditory input from the left side of the head to the right ear, and vice verse, thereby flipping the auditory input. This procedure is called Auditory Mirror Therapy (AMT).

Condition or Disease Intervention/Treatment Phase
  • Device: Auditory Mirror Therapy
N/A

Detailed Description

The goal of this study is to determine efficacy of a 21 day, 3 hours per day intervention of auditory mirror therapy (AMT) for chronic tinnitus. Hypothesis: AMT, as contrasted to a sham device, will significantly reduce symptom ratings on the Tinnitus Functional Index (TFI) scale. Along with TFI, additional measures will be collected every two days throughout the intervention; Tinnitus Handicap Index, Visual Analogue Scale, Minimum Masking Level (MML) and Residual Inhibition (RI), and Auditory Mirror Therapy Questionnaire.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Masking Description:
Concealment of treatment allocation is not possible
Primary Purpose:
Treatment
Official Title:
Evaluation of Auditory Mirror-therapy for Tinnitus
Actual Study Start Date :
Oct 4, 2022
Anticipated Primary Completion Date :
Apr 10, 2023
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Auditory Mirror Therapy Device

Modified 3M Peltor Tactical 300 Electronic Hearing Protector. The modification consists of connecting the left microphone to the right microphone tab on the circuit board, and vice versa.

Device: Auditory Mirror Therapy
21 days, up to 3 hours per day intervention

Sham Comparator: Sham Headphone Device

Non-Modified 3M Peltor Tactical 300 Electronic Hearing Protector

Device: Auditory Mirror Therapy
21 days, up to 3 hours per day intervention

Outcome Measures

Primary Outcome Measures

  1. Change in Tinnitus Functional Index (TFI) [3 weeks]

    25 question inventory that developed to provide a scaling of tinnitus severity, an identification of tinnitus domains with impact on the tinnitus severity, and a responsive measurement of change in tinnitus severity. The TFI will be used to determine the efficacy of a 21 day, 3 hours per day, intervention of auditory mirror-therapy (AMT) for chronic tinnitus

Secondary Outcome Measures

  1. Change in Tinnitus Handicap Inventory (THI) [3 weeks]

    a brief and psychometrically robust self-report measure used to quantify the impact of tinnitus on daily living.

  2. Change in Visual Analogue Scale (VAS) [3 weeks]

    Scale from 0 to 100 for tinnitus awareness, loudness and annoyance, on separate VAS. VAS loudness and annoyance are valid and effective measurements for capturing reductions in tinnitus severity in patients with chronic tinnitus

  3. Change in Minimum Masking Level (MML) and residual inhibition (RI) [3 weeks]

    MML is defined as the lowest tone intensity level required to cover or mask and individual's tinnitus. Correspondingly, the RI is considered the temporary decrease of tinnitus after a prolonged acoustic stimulation.

Other Outcome Measures

  1. Auditory Mirror Therapy Questionnaire [3 weeks]

    developed to qualitatively analyze how AMT is affecting participants' tinnitus throughout the intervention study. here

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male or Female

  • Ages 18-80 years old

  • Chronic Tinnitus (> 3months)

Exclusion Criteria:
  • Use of hearing aids

  • No history of significant drug or alcohol use

  • No history of debilitating neurological or psychiatric illnesses

  • No current or past history of balance-, vertigo- and/or vestibular- symptoms including Ménières disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Spaulding Rehabilitation Hospital Charlestown Massachusetts United States 02129

Sponsors and Collaborators

  • Spaulding Rehabilitation Hospital
  • Harvard University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nils Clas Linnman, Assistant Professor, Spaulding Rehabilitation Hospital
ClinicalTrials.gov Identifier:
NCT05710172
Other Study ID Numbers:
  • 2016P000820
First Posted:
Feb 2, 2023
Last Update Posted:
Feb 2, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 2, 2023